Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ultrasound treatment for high blood pressure under Long-Term watch

NCT ID NCT05027685

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 3000 people with high blood pressure who have been treated with the Paradise Ultrasound Renal Denervation System, a device that uses ultrasound to calm overactive kidney nerves. The goal is to see how safe and effective the treatment is over many years by monitoring blood pressure, kidney function, and quality of life. Participants are already receiving the device as part of their normal care, and the study simply collects their health data over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2022

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The GPS Registry will collect both retrospective and prospective data in patients treated as per the sites normal practice with the commercially available Paradise Ultrasound Renal Denervation System.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Appropriately signed and dated informed consent * Age ≥18 at time of consent * Patient candidate for renal denervation with the Paradise System based on physician's assessment OR Patient treated with the Paradise Ultrasound Renal Denervation System within the 6 months prior to consent Exclusion Criteria: Patients who meet any of the contraindications listed in the Instructions for Use will be excluded. The contraindications are: * Stented renal artery * Less than 18 years of age * Pregnant * Known allergy to contrast medium * Renal arteries diameter \< 3 mm and \> 8 mm * Renal artery with Fibromuscular (FMD) disease * Renal artery aneurysm * Renal artery stenosis of any origin \>30% * Iliac/femoral artery stenosis precluding insertion of the Paradise catheter

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    30 sites in 6 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Assistance Publique Hôpitaux de Marseille (AP-HM)

    WITHDRAWN

    Marseille, 13354, France

  • CHU Bordeaux Hôpital St. André

    ACTIVE_NOT_RECRUITING

    Bordeaux, France

  • CHU Grenoble Alpes - Hôpital Michallon

    ACTIVE_NOT_RECRUITING

    Grenoble, La Tronche, 38700, France

  • CHU Saint Pierre Brussels

    ACTIVE_NOT_RECRUITING

    Brussels, Belgium

  • Cardiovasculäres Centrum (CVC) Frankfurt

    WITHDRAWN

    Frankfurt, Germany

  • Castle Hill Hospital Hull

    ACTIVE_NOT_RECRUITING

    Hull, United Kingdom

  • Centre Hospitalier Princesse Grace Monaco

    ACTIVE_NOT_RECRUITING

    Monaco, Monaco

  • Centre Hospitalier de Pau

    ACTIVE_NOT_RECRUITING

    Pau, France

  • Charité Universitätsmedizin Berlin Campus Benjamin Franklin

    RECRUITING

    Berlin, Germany

  • Clinique CHS MontLégia

    ACTIVE_NOT_RECRUITING

    Liège, 4000, Belgium

  • Detusches Herzzentrum München (DHM)

    RECRUITING

    München, Germany

  • Erasmus MC Rotterdam

    RECRUITING

    Rotterdam, Netherlands

  • Freeman Hospital, Newcastle

    SUSPENDED

    Newcastle, United Kingdom

  • HEGP (Hôpital Européen Georges Pompidouv) Paris

    RECRUITING

    Paris, France

  • HUG Geneve Switzerland

    RECRUITING

    Geneva, Switzerland

  • Hammersmith Hospital (Imperial College Healthcare NHS Trust)

    ACTIVE_NOT_RECRUITING

    London, United Kingdom

  • Heart Center Lucerne -Luzerner Kantonsspital

    RECRUITING

    Lucerne, Switzerland

  • Herzzentrum Dresden GmbH Universitätsklinik

    RECRUITING

    Dresden, Germany

  • Herzzentrum Leipzig GmbH

    RECRUITING

    Leipzig, D-04289, Germany

  • Hospital Clinico Universitario S.Carlos

    TERMINATED

    Madrid, 28040, Spain

  • Hospital Universitario German Trias i Pujol

    TERMINATED

    Barcelona, 08916, Spain

  • Internistisches Klinikum München Süd GmbH, Klinik für Kardiologie und internistische Intensivmedizin

    NOT_YET_RECRUITING

    München, 83179, Germany

  • Kent and Canterbury Hospital, Canterbury

    ACTIVE_NOT_RECRUITING

    Canterbury, United Kingdom

  • Klinikum Coburg GmbH

    TERMINATED

    Coburg, Germany

  • Klinikum Lippe GmbH Detmold

    RECRUITING

    Detmold, Germany

  • Klinikum Wels-Grieskirchen GmbH

    RECRUITING

    Wels, 4600, Austria

  • Krankenhaus Maria Hilf Bad Neuenahr-Ahrweiler

    SUSPENDED

    Ahrweiler, 53474, Germany

  • Maastricht University Medical Center

    WITHDRAWN

    Maastricht, 6229, Netherlands

  • Marienhaus Klinikum Bendorf - Neuwied - Waldbreitbach

    NOT_YET_RECRUITING

    Neuwied, Germany

  • Marienhaus Klinikum Mainz

    RECRUITING

    Mainz, Germany

  • Medical University of Vienna,

    SUSPENDED

    Vienna, 1090, Austria

  • Noordwest Ziekenhuisgroep

    SUSPENDED

    Alkmaar, Netherlands

  • OLV Ziekenhuis Aalst

    ACTIVE_NOT_RECRUITING

    Aalst, Belgium

  • Queen Elizabeth Hospital, Glasgow

    ACTIVE_NOT_RECRUITING

    Glasgow, United Kingdom

  • Robert-Bosch-Krankenhaus GmbH Stuttgart

    RECRUITING

    Stuttgart, Germany

  • Royal Bournemouth Hospital, Bournemoth

    ACTIVE_NOT_RECRUITING

    Bournemouth, United Kingdom

  • Royal Brompton Hospital

    ACTIVE_NOT_RECRUITING

    London, United Kingdom

  • Russells Hall Hospital

    ACTIVE_NOT_RECRUITING

    Dudley, United Kingdom

  • Sana Kliniken Lübeck GmbH

    RECRUITING

    Lübeck, Germany

  • Schwarzwald-Baar Klinikum Villingen-Schwenningen

    RECRUITING

    Villingen-Schwenningen, Germany

  • St Thomas' Hospital

    ACTIVE_NOT_RECRUITING

    London, United Kingdom

  • St. Barbara-Klinik Hamm Heessen

    ACTIVE_NOT_RECRUITING

    Hamm, Germany

  • Städt. Klinikum Dresden (Standort Friedrichstadt)

    RECRUITING

    Dresden, Germany

  • UCL St Luc

    ACTIVE_NOT_RECRUITING

    Brussels, Belgium

  • University Clinic of Saarland - Homburg

    RECRUITING

    Homburg, D-66421, Germany

  • University Hospital Wales, Cardiff

    ACTIVE_NOT_RECRUITING

    Cardiff, United Kingdom

  • Universitäts-Herzzentrum Freiburg Bad Krozingen

    RECRUITING

    Bad Krozingen, Germany

  • Universitätsklinikum Düsseldorf

    RECRUITING

    Düsseldorf, Germany

  • Universitätsklinikum Erlangen

    RECRUITING

    Erlangen, Germany

  • Universitätsklinikum Halle (Saale), AöR

    RECRUITING

    Halle, 06120, Germany

  • Universitätsklinikum Köln

    RECRUITING

    Cologne, Germany

  • Universitätsklinikum der Ruhr-Universität Bochum, Medizinische Klinik II

    RECRUITING

    Herne, 44625, Germany

  • Universitätsmedizin der Johannes Gutenberg Universität Mainz

    RECRUITING

    Mainz, 55131, Germany

  • Universitätsspital Basel

    RECRUITING

    Basel, 4031, Switzerland

  • WHRC - Barts Health, London

    ACTIVE_NOT_RECRUITING

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.